• OPEN AN ACCOUNT
Indian Indices
Nifty
24,414.40 34.80
(0.14%)
Sensex
80,746.78 105.71
( 0.13%)
Bank Nifty
54,610.90 339.50
( 0.63%)
Nifty IT
35,920.30 51.10
( 0.14%)
Global Indices
Nasdaq
40,845.82 -394.01
(-0.96%)
Dow Jones
5,627.39 -43.99
(-0.78%)
Hang Seng
36,847.73 17.04
(0.05%)
Nikkei 225
8,559.33 -38.09
(-0.44%)
Forex
USD-INR
84.26 -0.32
(-0.38%)
EUR-INR
95.44 -0.12
(-0.12%)
GBP-INR
112.00 -0.18
(-0.16%)
JPY-INR
0.59 0.00
(0.28%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
360.7264827
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
26.18
121868.9
EPS(TTM)
Face Value()
Div & Yield %
57.63
2
0.86
 

NELCO reports consolidated net loss of Rs 4.08 crore in the March 2025 quarter
Apr 25,2025
Net loss of NELCO reported to Rs 4.08 crore in the quarter ended March 2025 as against net profit of Rs 6.10 crore during the previous quarter ended March 2024. Sales declined 17.27% to Rs 67.52 crore in the quarter ended March 2025 as against Rs 81.61 crore during the previous quarter ended March 2024.

For the full year,net profit declined 59.74% to Rs 9.53 crore in the year ended March 2025 as against Rs 23.67 crore during the previous year ended March 2024. Sales declined 4.82% to Rs 304.87 crore in the year ended March 2025 as against Rs 320.30 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales67.5281.61 -17 304.87320.30 -5
OPM %9.5418.04 -13.7718.54 -
PBDT7.5614.16 -47 41.8255.65 -25
PBT1.138.21 -86 19.6633.51 -41
NP-4.086.10 PL 9.5323.67 -60